Literature DB >> 23630639

The effect of pulsed dye laser on the dermatology life quality index in erythematotelangiectatic rosacea patients: an assessment.

Tang Ngee Shim1, Anthony Abdullah.   

Abstract

BACKGROUND: Erythematotelangiectatic rosacea is a common cutaneous disorder. It has a major psychosocial impact on a patient's life.
OBJECTIVE: This study aims to investigate the impact of pulsed dye laser on the quality of life of affected patients as measured by the Dermatology Life Quality Index.
METHODS: The authors report a prospective study of 20 patients (in a wide range of skin phototypes) attending a laser clinic. All patients completed the Dermatology Life Quality Index questionnaires before and after three sessions of laser treatment.
RESULTS: The mean Dermatology Life Quality Index scores pre- and post-laser treatment were 17.3 and 4.3, respectively. All patients experienced a statistically significant improvement in their quality of life (p<0.0001, paired t test).
CONCLUSION: The Dermatology Life Quality Index questionnaire (pre- and post-laser treatment) is an important tool for monitoring the efficacy of therapy and patient satisfaction.

Entities:  

Year:  2013        PMID: 23630639      PMCID: PMC3638853     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  8 in total

1.  Laser treatment of erythema and telangiectasia associated with rosacea.

Authors:  S M Clark; S W Lanigan; R Marks
Journal:  Lasers Med Sci       Date:  2002       Impact factor: 3.161

2.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

Review 3.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Sharon Kramer; Ben Carter; Mark A Graber; Zbys Fedorowicz
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

Review 4.  Rosacea and its management: an overview.

Authors:  A K Gupta; M M Chaudhry
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-05       Impact factor: 6.166

5.  Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea.

Authors:  Isaac M Neuhaus; Lee T Zane; Whitney D Tope
Journal:  Dermatol Surg       Date:  2009-04-06       Impact factor: 3.398

6.  Long-pulsed (6-ms) pulsed dye laser treatment of rosacea-associated telangiectasia using subpurpuric clinical threshold.

Authors:  Zaid F Jasim; Wai Kit Woo; Julian M Handley
Journal:  Dermatol Surg       Date:  2004-01       Impact factor: 3.398

7.  Quality of life and rosacea: pulsed dye laser impact.

Authors:  Nuno Menezes; Ana Moreira; Gioconda Mota; Armando Baptista
Journal:  J Cosmet Laser Ther       Date:  2009-09       Impact factor: 2.247

8.  Laser treatment of rosacea: a pathoetiological study.

Authors:  Solbritt Lonne-Rahm; Klas Nordlind; Desiree Wiegleb Edström; Anne-Marie Ros; Mats Berg
Journal:  Arch Dermatol       Date:  2004-11
  8 in total
  5 in total

Review 1.  Laser and light-based therapies in the management of rosacea: an updated systematic review.

Authors:  Husein Husein-ElAhmed; Martin Steinhoff
Journal:  Lasers Med Sci       Date:  2021-01-03       Impact factor: 3.161

Review 2.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

3.  Update on the management of rosacea.

Authors:  Allison P Weinkle; Vladyslava Doktor; Jason Emer
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-07

Review 4.  Psychosocial aspects of rosacea with a focus on anxiety and depression.

Authors:  Monika Heisig; Adam Reich
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-03-06

5.  The effects of photobiomodulation therapy on inflammatory mediators, immune infiltration, and angiogenesis in a mouse model of rosacea.

Authors:  Shuwei Wu; Yaoxi Su; Lian Wang; Bensen Sun; Xian Jiang
Journal:  Ann Transl Med       Date:  2022-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.